1.
|
8 p, 799.5 KB |
Periaqueductal gray matter echogenicity as a marker of migraine chronification : a case control study
/
Vilas, Dolores (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rubio, Sara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gea, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ríos, José (Universitat Autònoma de Barcelona) ;
Ispierto, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Hernández-Pérez, María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Paré-Curell, Martí (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Millán, Mònica (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Dorado Bouix, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Migraine is one of the most prevalent and disabling medical diseases in the world. The periaqueductal gray matter and the red nucleus play an important role in its pathogenesis. Our aim was to evaluate the echogenicity of the periaqueductal gray matter and the red nucleus in patients with migraine, by means of transcranial ultrasound. [...]
2023 - 10.1186/s10194-023-01576-3
Journal of headache and pain, Vol. 24 (april 2023)
|
|
2.
|
13 p, 1.9 MB |
A study of differential microRNA expression profile in migraine : the microMIG exploratory study
/
Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gómez-Galván, J. B. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Asskour, L. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron) ;
Caronna, Edoardo (Hospital Universitari Vall d'Hebron) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Several studies have described potential microRNA (miRNA) biomarkers associated with migraine, but studies are scarcely reproducible primarily due to the heterogeneous variability of participants. Increasing evidence shows that disease-related intrinsic factors together with lifestyle (environmental factors), influence epigenetic mechanisms and in turn, diseases. [...]
2023 - 10.1186/s10194-023-01542-z
Journal of headache and pain, Vol. 24 (february 2023)
|
|
3.
|
|
4.
|
19 p, 1.9 MB |
Neuromodulation in headache and craniofacial neuralgia : guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery Neuromodulación en cefaleas y neuralgias craneofaciales: Guía de la Sociedad Española de Neurología y de la Sociedad Española de Neurocirugía
/
Belvís, Roberto (Institut d'Investigació Biomèdica Sant Pau) ;
Irimia, P. (Clínica Universidad de Navarra) ;
Seijo-Fernández, F. (Centro Médico Asturias) ;
Paz, J. (Hospital Universitario La Paz (Madrid)) ;
García-March, G. (Hospital Clínico Universitario) ;
Santos-Lasaosa, S. (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Latorre, G. (Hospital Universitario de Fuenlabrada ( Madrid)) ;
González-Oria, Carmen (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Rodríguez, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Pozo-Rosich, P. (Hospital Universitari Vall d'Hebron) ;
Lainez-Andres, J. M (Hospital Clínico Universitario)
Introduction: Numerous invasive and non-invasive neuromodulation devices have been developed and applied to patients with headache and neuralgia in recent years. However, no updated review addresses their safety and efficacy, and no healthcare institution has issued specific recommendations on their use for these 2 conditions. [...]
2021 - 10.1016/j.nrl.2020.04.022
Neurología, Vol. 36 Núm. 1 (enero 2021) , p. 61-79
|
|
5.
|
|
6.
|
10 p, 705.8 KB |
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life : Expert consensus on definitions from a Delphi process
/
Steiner, Timothy J (Imperial College London) ;
Terwindt, Gisela M (Leiden University Medical Center) ;
Katsarava, Zaza (EVEX Medical Corporation (Georgia)) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gantenbein, Andreas R (University Hospital Zurich (Suïssa)) ;
Roche, Sarah L (Eli Lilly and Company) ;
Dell'Agnello, Grazia (Eli Lilly Italia SpA) ;
Tassorelli, Cristina (IRCCS Mondino Foundation) ;
Universitat Autònoma de Barcelona
Migraine-attributed burden, impact, disability and migraine-impacted quality of life are important concepts in clinical management, clinical and epidemiological research, and health policy, requiring clear and agreed definitions. [...]
2022 - 10.1177/03331024221110102
Cephalalgia, Vol. 42 (july 2022) , p. 1387-1396
|
|
7.
|
12 p, 503.9 KB |
Excellent Response to OnabotulinumtoxinA : Different Definitions, Different Predictors
/
Ornello, Raffaele (University of L'Aquila) ;
Baraldi, Carlo (AOU Policlinico di Modena) ;
Ahmed, Fayyaz (Hull University Teaching Hospitals) ;
Negro, Andrea (Sapienza University) ;
Miscio, Anna Maria (Fondazione IRCCS "Casa Sollievo Della Sofferenza") ;
Santoro, Antonio (Fondazione IRCCS "Casa Sollievo Della Sofferenza") ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Russo, Antonio (University of Campania "Luigi Vanvitelli") ;
Silvestro, Marcello (University of Campania "Luigi Vanvitelli") ;
Cevoli, Sabina (IRCCS Istituto delle Scienze Neurologiche di Bologna) ;
Brunelli, Nicoletta (Campus Bio-Medico University Hospital (Itàlia)) ;
Vernieri, Fabrizio (Campus Bio-Medico University Hospital (Itàlia)) ;
Grazzi, Licia (IRCCS Foundation "Carlo Besta" Neurological Institute) ;
Pani, Luca (VeraSci (Estats Units d'Amèrica)) ;
Andreou, Anna P (Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ;
Lambru, Giorgio (Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ;
Frattale, Ilaria (Tor Vergata University) ;
Kamm, Katharina (Ludwig Maximilians University München) ;
Ruscheweyh, Ruth (Ludwig Maximilians University München) ;
Russo, Marco (Azienda USL-IRCCS di Reggio Emilia) ;
Torelli, Paola (University of Parma) ;
Filatova, Elena (Sechenov First Moscow State Medical University) ;
Latysheva, Nina (Sechenov First Moscow State Medical University) ;
Gryglas-Dworak, Anna (Headache Center Wroclaw) ;
Straburzyński, Marcin (University of Warmia and Mazury) ;
Butera, Calogera (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Colombo, Bruno (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Filippi, Massimo (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martelletti, Paolo (Sapienza University) ;
Guerzoni, Simona (University of Modena and Reggio Emilia) ;
Sacco, Simona (University of L'Aquila) ;
Universitat Autònoma de Barcelona
The identification of patients who can benefit the most from the available preventive treatments is important in chronic migraine. We explored the rate of excellent responders to onabotulinumtoxinA in a multicenter European study and explored the predictors of such response, according to different definitions. [...]
2022 - 10.3390/ijerph191710975
International journal of environmental research and public health, Vol. 19 (september 2022)
|
|
8.
|
|
9.
|
8 p, 761.9 KB |
MAB-MIG : registry of the spanish neurological society of erenumab for migraine prevention
/
Belvís, Roberto (Institut d'Investigació Biomèdica Sant Pau) ;
Irimia, Pablo (Clínica Universidad de Navarra) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
González-Oria, Carmen (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Cano, Antonio (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Viguera, Javier (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Sánchez, Belén (Hospital Quirónsalud Zaragoza) ;
Molina, Francisco (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Beltrán, Isabel (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Oterino, Agustín (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Cuadrado-Godia, Elisa (Hospital del Mar (Barcelona, Catalunya)) ;
Gómez-Camello, Angel (Hospital Universitario San Cecilio (Granada)) ;
Alberte-Woodward, Miguel (Hospital Universitario Lucus Augusti (Lugo)) ;
Jurado, Carmen (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Oms, Teresa (Hospital Dos de Maig) ;
Ezpeleta, David (Hospital Quironsalud Madrid) ;
de Terán, Javier Díaz (Hospital Universitario La Paz (Madrid)) ;
Morollón Sánchez-Mateos, Noemí (Hospital Universitari Dexeus (Barcelona, Catalunya)) ;
Latorre, Germán (Hospital Universitario de Fuenlabrada ( Madrid)) ;
Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lamas, Raquel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Toledano, Carlos (Clínica Universidad de Navarra) ;
Leira, Rogelio (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Santos, Sonia (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Del Rio, Margarita Sanchez (Clínica Universidad de Navarra) ;
Universitat Autònoma de Barcelona
Erenumab was approved in Europe for migraine prevention in patients with ≥ 4 monthly migraine days (MMDs). In Spain, Novartis started a personalized managed access program, which allowed free access to erenumab before official reimbursement. [...]
2021 - 10.1186/s10194-021-01267-x
Journal of headache and pain, Vol. 22 (july 2021)
|
|
10.
|
11 p, 1005.5 KB |
Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18 FDG-PET and MRI study
/
Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pareto, Deborah (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cuberas-Borrós, Gemma (Hospital Universitari Vall d'Hebron) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Caronna, Edoardo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vila-Balló, Adrià (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lorenzo-Bosquet, Carles (Hospital Universitari Vall d'Hebron) ;
Castell-Conesa, Joan (Hospital Universitari Vall d'Hebron) ;
Rovira, Alex (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
To describe interictal brain structural and metabolic differences between patients with episodic migraine (EM), chronic migraine (CM) and healthy controls (HC). This is an exploratory study including right-handed age-matched women with EM, CM and HC. [...]
2021 - 10.1186/s10194-021-01289-5
Journal of headache and pain, Vol. 22 (july 2021)
|
|